CAMDI interacts with the human memory-associated protein KIBRA and regulates AMPAR cell surface expression and cognition.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Little is known about the molecular mechanisms of cognitive deficits in psychiatric disorders. CAMDI is a psychiatric disorder-related factor, the deficiency of which in mice results in delayed neuronal migration and psychiatrically abnormal behaviors. Here, we found that CAMDI-deficient mice exhibited impaired recognition memory and spatial reference memory. Knockdown of CAMDI in hippocampal neurons increased the amount of internalized alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR) and attenuated the chemical long-term potentiation (LTP)-dependent cell surface expression of AMPAR. KIBRA was identified as a novel CAMDI-binding protein that retains AMPAR in the cytosol after internalization. KIBRA inhibited CAMDI-dependent Rab11 activation, thereby attenuating AMPAR cell surface expression. These results suggest that CAMDI regulates AMPAR cell surface expression during LTP. CAMDI dysfunction may partly explain the mechanism underlying cognitive deficits in psychiatric diseases.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Neuron. 2001 Jan;29(1):243-54. (PMID: 11182095)
      Mol Biol Cell. 1999 Jan;10(1):47-61. (PMID: 9880326)
      Front Cell Neurosci. 2014 Nov 12;8:381. (PMID: 25429259)
      Nat Cell Biol. 2007 Dec;9(12):1370-80. (PMID: 17994011)
      Proc Natl Acad Sci U S A. 2002 May 14;99(10):7096-101. (PMID: 12011465)
      Neuron. 2011 Sep 22;71(6):1022-9. (PMID: 21943600)
      Science. 2006 Oct 20;314(5798):475-8. (PMID: 17053149)
      Cell Mol Life Sci. 2017 Oct;74(19):3533-3552. (PMID: 28516224)
      Neuropsychopharmacology. 2010 Sep;35(10):2110-9. (PMID: 20571483)
      Hippocampus. 2006;16(5):443-52. (PMID: 16463388)
      J Neurosci. 2007 Dec 12;27(50):13903-8. (PMID: 18077702)
      Neuron. 2004 Jul 22;43(2):221-36. (PMID: 15260958)
      Nat Rev Drug Discov. 2012 Feb 01;11(2):141-68. (PMID: 22293568)
      J Neurosci. 2010 Dec 8;30(49):16437-52. (PMID: 21147983)
      Neurobiol Learn Mem. 2016 Nov;135:100-114. (PMID: 27498008)
      Front Neuroanat. 2015 Feb 20;9:13. (PMID: 25750616)
      J Biol Chem. 2010 Dec 24;285(52):40554-61. (PMID: 20956536)
      Biochem Soc Trans. 2010 Apr;38(2):460-5. (PMID: 20298203)
      EMBO Rep. 2016 Dec;17(12):1785-1798. (PMID: 27737934)
      PLoS One. 2012;7(2):e30643. (PMID: 22363459)
      Neuron. 2009 Jul 16;63(1):92-105. (PMID: 19607795)
      Schizophr Bull. 2016 Mar;42(2):288-300. (PMID: 26405221)
      Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19038-43. (PMID: 20956289)
      Neuron. 2007 Sep 20;55(6):874-89. (PMID: 17880892)
      J Neurosci. 2011 Jul 6;31(27):9933-44. (PMID: 21734285)
      Schizophr Bull. 2017 Oct 21;43(6):1304-1314. (PMID: 28525603)
      J Neurosci. 2008 Jul 30;28(31):7820-7. (PMID: 18667614)
      Science. 2004 Sep 24;305(5692):1972-5. (PMID: 15448273)
      J Neurosci. 2011 Jan 26;31(4):1448-60. (PMID: 21273429)
      Neuron. 2000 Nov;28(2):511-25. (PMID: 11144360)
      Neuron. 2005 Aug 4;47(3):407-21. (PMID: 16055064)
      Biochem Biophys Res Commun. 2004 May 7;317(3):703-7. (PMID: 15081397)
    • Accession Number:
      0 (CCDC141 protein, mouse)
      0 (Intracellular Signaling Peptides and Proteins)
      0 (Nerve Tissue Proteins)
      0 (Phosphoproteins)
      0 (Receptors, AMPA)
      0 (Wwc1 protein, mouse)
      EC 3.6.1.- (rab11 protein)
      EC 3.6.5.2 (rab GTP-Binding Proteins)
    • Publication Date:
      Date Created: 20191116 Date Completed: 20200323 Latest Revision: 20200323
    • Publication Date:
      20240104
    • Accession Number:
      PMC6857912
    • Accession Number:
      10.1371/journal.pone.0224967
    • Accession Number:
      31730661